Found 11 matching trials
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL PHASE2 The purpose of this study is to compare the efficacy and safety of genotype...
Show More Location
Ruijin Hospital, Shanghai JiaoTong University School of Medicine
Learn More & Join Trial
Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma PHASE1 The purpose of this study is to is to determine the effects (good and bad) ...
Show More Location
University of Miami
Learn More & Join Trial
AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL PHASE2 This is a prospective, open-label, multicenter, randomized controlled study...
Show More Learn More & Join Trial
Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This is a prospective, single-arm, single-center clinical study. This clini...
Show More Location
Zhongshan Hospital,Fudan University
Learn More & Join Trial
The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma PHASE3 A multicenter, prospective, randomized, open-label, controlled trial to eva...
Show More Location
Shanghai Institute of Hematology, Rui-Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL PHASE2 This is a prospective, open-label, multicenter, randomized controlled study...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Polatuzumab Vedotin and Zanubrutinib Plus R-CHP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL PHASE2 Aim of this study will evaluate the efficacy and safety of Polatuzumab Vedo...
Show More Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma PHASE2 This is a prospective, single-arm, single-center clinical study. This clini...
Show More Location
Zhongshan Hospital,Fudan University
Learn More & Join Trial
Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes PHASE2 This is a prospective, open-label, single-arm, single-center, Phase II clin...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This is a prospective, multicenter, single-arm, open phase II study to expl...
Show More Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial